Difficult-to-treat Beh?et syndrome: A therapeutic approach

被引：4

作者：

Yazici, Yusuf ^{[1
]}

Hatemi, Gulen ^{[2
,3
]}

机构：

[1] NYU Grossman Sch Med, Med, New York, NY 10016 USA

[2] Istanbul Univ Cerrahpasa, Sch Med, Dept Internal Med, Div Rheumatol,Med, Istanbul, Turkiye

[3] Istanbul Univ Cerrahpasa, Behcets Dis Res Ctr, Istanbul, Turkiye

来源：

CLINICAL IMMUNOLOGY | 2023年 / 249卷

关键词：

Behcet syndrome; Outcomes; Disease activity; Azathioprine; Personalized medicine; BEHCETS-DISEASE; DOUBLE-BLIND; FOLLOW-UP; TRIAL; APREMILAST; DIAGNOSIS; EFFICACY; PHASE-2;

D O I：

10.1016/j.clim.2023.109272

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Behcet syndrome is a systemic vasculitis which can involve many different organ systems. As such, treatment decisions need to be based on organ system involved. In addition, specific patient characteristics potentially predict milder or more severe course, and all these factors need to be taken into consideration when making treatment decisions. In this paper, we review the current approaches to treating Behcet syndrome patients.

引用

收藏

页数：4

相关论文

共 33 条

[1] Predictors for the risk and severity of post-thrombotic syndrome in vascular Behcet's disease [J].

Aksoy, Aysun ;

Colak, Seda ;

Yagiz, Burcu ;

Coskun, Belkis Nihan ;

Omma, Ahmet ;

Yildiz, Yasin ;

Sari, Alper ;

Atas, Nuh ;

Ilgin, Can ;

Karadag, Omer ;

Erden, Abdulsamet ;

Dalkilic, Ediz ;

Bolca, Naile ;

Ergelen, Rabia ;

Onur, Mehmet Ruhi ;

Direskeneli, Haner ;

Alibaz-Oner, Fatma .

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2021, 9 (06) :1451-1459

[2] Unmet need in Behcet's disease: most patients in routine follow-up continue to have oral ulcers [J].

Alibaz-Oner, Fatma ;

Mumcu, Gonca ;

Kubilay, Zeynep ;

Ozen, Gulsen ;

Celik, Gulce ;

Karadeniz, Asli ;

Can, Meryem ;

Oner, Sibel Yilmaz ;

Inanc, Nevsun ;

Atagunduz, Pamir ;

Ergun, Tulin ;

Direskeneli, Haner .

CLINICAL RHEUMATOLOGY, 2014, 33 (12) :1773-1776

[3] The right place of interleukin-1 inhibitors in the treatment of Behcet's syndrome: a systematic review [J].

Bettiol, Alessandra ;

Silvestri, Elena ;

Di Scala, Gerardo ;

Amedei, Amedeo ;

Becatti, Matteo ;

Fiorillo, Claudia ;

Lopalco, Giuseppe ;

Salvarani, Carlo ;

Cantarini, Luca ;

Soriano, Alessandra ;

Emmi, Giacomo .

RHEUMATOLOGY INTERNATIONAL, 2019, 39 (06) :971-990

[4] An update on the diagnosis, treatment, and prognosis of intestinal Behcet's disease [J].

Cheon, Jae Hee ;

Kim, Won Ho .

CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (01) :24-31

[5] Lack of efficacy of tocilizumab in mucocutaneous Behcet's syndrome: report of two cases [J].

Diamantopoulos, Andreas P. ;

Hatemi, Gulen .

RHEUMATOLOGY, 2013, 52 (10) :1923-1924

[6] Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behcet's Syndrome A Retrospective Study of Seventy Patients With Vascular Involvement [J].

Emmi, Giacomo ;

Vitale, Antonio ;

Silvestri, Elena ;

Boddi, Maria ;

Becatti, Matteo ;

Fiorillo, Claudia ;

Fabiani, Claudia ;

Frediani, Bruno ;

Emmi, Lorenzo ;

Di Scala, Gerardo ;

Goldoni, Matteo ;

Bettiol, Alessandra ;

Vaglio, Augusto ;

Cantarini, Luca ;

Prisco, Domenico .

ARTHRITIS & RHEUMATOLOGY, 2018, 70 (09) :1500-1507

[7]

Esatoglu Sinem Nihal, 2018, Clin Exp Rheumatol, V36, P90

[8] Factors influencing the recurrence of arterial involvement after surgical repair in Behcet disease [J].

Gaudric, Julien ;

Jayet, Jeremie ;

Saadoun, David ;

Couture, Thibault ;

Ferfar, Yasmina ;

Davaine, Jean Michel ;

Cacoub, Patrice ;

Chiche, Laurent ;

Koskas, Fabien .

JOURNAL OF VASCULAR SURGERY, 2020, 72 (05) :1761-1769

[9] Long term follow-up of Behcet's syndrome patients treated with cyclophosphamide [J].

Gurcan, Mert ;

Esatoglu, Sinem Nihal ;

Hamuryudan, Vedat ;

Saygin, Didem ;

Ugurlu, Serdal ;

Seyahi, Emire ;

Melikoglu, Melike ;

Fresko, Izzet ;

Yurdakul, Sebahattin ;

Yazici, Hasan ;

Hatemi, Gulen .

RHEUMATOLOGY, 2020, 59 (09) :2264-2271

[10] Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial [J].

Hamuryudan, V ;

Mat, C ;

Saip, S ;

Ozyazgan, Y ;

Siva, A ;

Yurdakul, S ;

Zwingenberger, K ;

Yazici, H .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (06) :443-+

← 1 2 3 4 →